side effects with tirzepatide Understanding Effects, Risks & Treatment Comparative safety and side effects

3.1 GLP-1R agonists in the cardiovascular system GLP-1R is expressed in the heart and vasculature, raising the possibility that GLP-1 might have both direct and indirect actions on the cardiovascular system (Ussher and Drucker, 2023)

Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY relative to placebo on major adverse cardiovascular events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity)

Addressing both weight and hormonal health simultaneously often produces outcomes that neither treatment achieves alone

If it is stored in a refrigerator, remove it 30 minutes before injecting it

Additional file 1: Fig

A study in a Chinese POI pedigree identified BNC1 mutations that lead to premature follicular activation and atresia (Zhang et al., 2018)